Dexcom (DXCM) Receivables - Other (2018 - 2026)

Dexcom (DXCM) has reported Receivables - Other for 9 consecutive years, with $19.9 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Receivables - Other rose 17.06% year-over-year to $19.9 million in Q2 2026; TTM through Jun 2026 was $19.9 million, a 17.06% increase from a year earlier, with the FY2025 full-year figure at $16.9 million, up 11.18% from the prior year.
• Receivables - Other was $19.9 million for Q2 2026 at Dexcom, up from $16.9 million in the prior quarter.
• Over five years, Receivables - Other peaked at $19.9 million in Q2 2026 and troughed at $8.0 million in Q4 2023.
• A 5-year average of $12.8 million and a median of $12.1 million in 2022 frame the typical range for Receivables - Other.
• Across the five-year window, Receivables - Other fell 16.22% in 2022 and surged 90.0% in 2024, its largest moves.
• Over 5 years, Receivables - Other stood at $9.0 million in 2022, then declined by 11.11% to $8.0 million in 2023, then surged by 90.0% to $15.2 million in 2024, then climbed by 11.18% to $16.9 million in 2025, then advanced by 17.75% to $19.9 million in 2026.
• The last three Receivables - Other figures came in at $19.9 million (Q2 2026), $16.9 million (Q1 2026), and $16.9 million (Q4 2025), per Business Quant data.